Martin H. Huber Jr.

SVP & Chief Medical Officer, Tesaro.

Companies

ACTUATE THERAPEUTICS, INC.Board member May 6, 2026 to now¹
Mersana Therapeutics (United States)Chief executive officer Sep 13, 2023 to now²
Mersana Therapeutics (United States)President Sep 13, 2023 to now²
Syndax Pharmaceuticals IncBoard member Sep 17, 2021 to now³
Mersana Therapeutics (United States)Board member Jun 24, 2020 to now⁴
Xilio Therapeutics, Inc.President Oct 21, 2021 to Aug 18, 2023⁵
TesaroSVP & Chief Medical Officer Sep 22, 2015 to Jan 22, 2019⁶

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 4, 2026Granted 24,000 shares of Syndax Pharmaceuticals Inc⁷
Jan 6, 2026U 9,573 shares of Mersana Therapeutics (United States)⁸
Sep 12, 2025Sold 2,012 shares at $7.31 of Mersana Therapeutics (United States)⁹
Sep 11, 2025Exercised options 6,670 shares of Mersana Therapeutics (United States)⁹
May 19, 2025Bought 5,000 shares at $8.99 of Syndax Pharmaceuticals Inc¹⁰
Feb 5, 2025Granted 25,000 shares of Syndax Pharmaceuticals Inc¹¹
Jan 16, 2025Sold 4,514 shares at $0.58 of Mersana Therapeutics (United States)¹²
Jan 15, 2025Exercised options 11,062 shares of Mersana Therapeutics (United States)¹²
Sep 12, 2024Sold 50,423 shares at $1.76 of Mersana Therapeutics (United States)¹³
Sep 11, 2024Exercised options 166,750 shares of Mersana Therapeutics (United States)¹³
Feb 7, 2024Granted 17,000 shares of Syndax Pharmaceuticals Inc¹⁴
Jun 8, 2023Granted 14,467 shares of Mersana Therapeutics (United States)¹⁵
Feb 2, 2023Granted 16,000 shares of Syndax Pharmaceuticals Inc¹⁶
Feb 2, 2022Granted 16,000 shares of Syndax Pharmaceuticals Inc¹⁷

The numbers on this page point here. Each one links to the record it came from.